Comparison and Agreement of LDL-C Formulas in Cardiovascular Risk Stratification among Malaysians
DOI:
https://doi.org/10.21834/e-bpj.v10i34.7352Keywords:
LDL-C Formula, Friedewald, Martin-Hopkins, SampsonAbstract
Several formulas have been developed to estimate the LDL-C values, such as the Friedewald, Martin-Hopkins, Sampson, and Anandaraja equations. However, their performance has not been extensively evaluated. Therefore, this study aimed to evaluate the agreement of these LDL-C formulas and analyze the clinical LDL-C group reclassification. The results showed that Friedewald consistently underestimates LDL-C compared to the others, but reclassification using Martin or Sampson may not align with Friedewald-based risk categorization. Anandaraja showed the highest misclassification. These discrepancies may affect treatment decisions. Future studies should validate performance in high-risk subgroups and consider formula-specific cut-offs to improve cardiovascular risk assessment.
References
Aly, H., Baiomy, N., Saad, W., & Elmihi, N. (2025). A comparison study between Martin/Hopkin’s and Sampson’s equations and the traditionally used Friedewald’s equation for more accurate estimation of low-density lipoprotein cholesterol. Ain Shams Medical Journal, 76(1), 109-123.
Anandaraja, S., Narang, R., Godeswar, R., Laksmy, R., & Talwar, K. K. (2005). Low-density lipoprotein cholesterol estimation by a new formula in Indian population. International Journal of Cardiology, 102(1), 117-120.
David-Pardo, D., Morales-Rodríguez, J. I., Rodríguez-Cely, L. C., Pinzón-Mora, C. A., Moreno-García, S. C., & Pardo-Oviedo, J. M. (2024). Concordance between LDL-C estimated by various formulas and directly measured LDL-C. Journal of Clinical Lipidology. 18(6), 926-937.
Department of Statistics Malaysia. (2020). Statistics on causes of death, Malaysia, 2019. Putrajaya: Department of Statistics Malaysia.
Ference, B. A., Wilson, D. P., & others. (2020). The Expected 30-Year Benefits of Early Versus Delayed Primary Prevention of Cardiovascular Disease by Lipid Lowering. Circulation, 142(7), 621-635
Firus Khan, A. Y., Ramli, A. S., Abdul Razak, S., Mohd Kasim, N. A., Chua, Y.-A., Ul-Saufie, A. Z., Jalaludin, M. A., & Nawawi, H., on behalf of the MyHEBAT Study Investigators. (2022). The Malaysian Health and Wellbeing Assessment (MyHEBAT) study protocol: An initiation of a national registry for extended cardiovascular risk evaluation in the community. International Journal of Environmental Research and Public Health, 19(18), 11789.
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry, 18(6), 499-502.
Gasko, R. (2006). Low-density lipoprotein cholesterol estimation by the Anandaraja’s formula — confirmation. Lipids in Health and Disease, 18(5), 1-2.
Grant, J. K., Kaufman, H. W., Martin, S. S. (2024) Extensive evidence supports the Martin–Hopkins equation as the LDL-C calculation of choice. Clinical chemistry, 70(2):392-8.
Grundy, S. M., Stone, N. J., Bailey, A. L., et al. (2019). 2018 AHA/ACC guideline on the management of blood cholesterol: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 139(25), e1082-e1143.
Gupta, S., Verma, M.,&Singh, K. (2012). Does LDL-C estimation using Anandaraja’s formula give a better agreement with direct LDL-C estimation than the Friedewald’s formula?. Indian Journal of Clinical Biochemistry, 27(2), 127–133.
Iacobucci, D., Román, S., Moon, S., & Rouziès, D. (2025). A tutorial on what to do with skewness, kurtosis, and outliers: New insights to help scholars conduct and defend their research. Psychology&Marketing, 42(5), 1398-1414.
Institute for Public Health. (2023). National Health and Morbidity Survey (NHMS) 2023: Non-communicable diseases, risk factors & other health problems. Ministry of Health Malaysia.
Li, J., Xin, Y., Li, J., Meng, M., Zhou, L., Qiu, H., Chen, H.,&Li, H. (2022). Evaluation of the Sampson equation for LDL-C in acute coronary syndrome patients: A Chinese population-based cohort study. Lipids in Health and Disease, 21(1), 39.
Ling. I. L. C., Hee, M. Q., & Farrukh, M. J. (2022). Knowledge, attitude and consumption pattern of alcohol among university students at a private university in Kuala Lumpur, Malaysia: A cross-sectional study. Malaysian Journal of Public Health Medicine, 22(3), 63-79.
Martin, S. S., Blaha, M. J., Elshazly, M. B., Toth, P. P., Jones, S. R., & Fonseca, F. A. (2013). Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. Journal of the American Medical Association, 310(19), 2061-2068.
Ministry of Health Malaysia. (2023). National Diabetes Registry report 2023. Disease Control Division, Ministry of Health Malaysia.
Nazli, S. A., Rosman, A., Mohd Kasim, N. A., Al-Khateeb, A., Ul-Saufie, A. Z., Md Radzi, A. B., Ibrahim, K. S., Kasim, S. S., & Nawawi, H. (2024). Coronary risk factor profiles according to different age categories in premature coronary artery disease patients who have undergone percutaneous coronary intervention. Scientific Reports, 14(1), 15326.
Nuwaylati, D. A., & Awan, Z. A. (2024). A novel equation for the estimation of low-density lipoprotein cholesterol in the Saudi Arabian population: A derivation and validation study. Scientific Reports, 14(1):5478.
Rahim, I. N. A., Kasim, N. A. M., [Coauthors]. (2024). Comparison of directly measured LDL-C with calculated LDL-C using Friedewald, de Cordova, Ahmadi, and Vujovic formulas. Malaysian Journal of Clinical Biochemistry, 1(1), 1-13.
Razman, A. Z., Baharudin, N., Mohd Kasim, N. A., Al-Khateeb, A., Ismail, Z., & Nawawi, H., on behalf of the MyHEBAT-CRES Investigators. (2022). Undertreatment and Underachievement of LDL-C Target among Individuals with High and Very High Cardiovascular Risk in the Malaysian Community. Healthcare, 10(12), 2448.
Sajja, A., Park, J., Sathiyakumar, V., et al. (2021). Comparison of methods to estimate low-density lipoprotein cholesterol in patients with high triglyceride levels. JAMA Network Open, 4(10), e2128817.
Sampson, M., Ling, C., Sun, Q., Harb, R., Ashmaig, M., Warnick, R., Sethi, A., Fleming, J. K., Otvos, J. D., Meeusen, J. W., Delaney, S. R., Jaffe, A. S., Shamburek, R., Amar, M., & Remaley, A. T. (2020). A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and/or hypertriglyceridemia. JAMA Cardiology, 5(5), 540-548.
Solnica, B., Sygitowicz, G., Sitkiewicz, D., Jóźwiak, J., Kasperczyk, S., Broncel, M., Wolska, A., Odrowąż-Sypniewska, G.,&Banach, M. (2024). 2024 guidelines of the Polish Society of Laboratory Diagnostics and the Polish Lipid Association on laboratory diagnostics of lipid metabolism disorders. Archives of Medical Science, 20(2), 357–374.
Sun, C. J., McCudden, C., Brisson, D., Shaw, J., Gaudet, D., & Ooi, T. C. (2023). Comparison of three methods for LDL-C calculation for cardiovascular disease risk categorisation in three distinct patient populations. Canadian Journal of Cardiology, 39(5), 668-677.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Noor Alicezah Mohd Kasim, Yung-An Chua, Nurain Ibrahim, Putrya Hawa

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.